Eldricare, the subsidiary of US-based ZeOmega, an industry leader in population health management (PHM) solutions, has now seen that follow-ups in patient care can strengthen the doctor-patient relationship and lower the cost for chronic treatment. Globally, hospitals are actively working with follow-care and home health players to build a post-care market. Over the past several years, a number of hospitals have signed-in follow-up care companies to manage and assist their patients after they are done with doctor consultation. In India, follow-up care is a niche field. This business model gains significance for India going by the rise in non-communicable diseases which account for 60 percent of fatality. Here shortage of specialists and surplus patients have resulted in a skewed doctor: patient ratio of 1:1800. It is high time healthcare providers engage with follow-up care experts to contain the early onset of NCDs, Anand Tiwari, senior director- product management, Eldricare told.
Early this year, Eldricare began working with MS Ramaiah Hospital, Bengaluru. Here is supports 5000 patients. ZeOmega has developed with Jiva a population health management platform which allows hospitals, doctors, nurses and patients to access related medical information in a secured manner. Our concept of Live Coaches hand-hold patients for regular check-ups, follow up care, and advice on lifestyle habits. It reduces the burden on doctors and hastens the recovery process for patients. But we see that India needs more participation from independent health service providers willing allow follow-up care, he added. The company’s objective is to have a strong foothold in India by building a well-organized follow-up care-giver network. “We intend to rope in health systems and hospitals to cater to the patients in a cost-effective way. More than the acceptance of this business model is the awareness that needs to be created about the benefits of follow-up care in terms of cost and patient recovery,” said Tiwari.
Even though there are effective prevention and treatment strategies for major NCDs like hypertension and diabetes, their management vis-a-vis diagnostics, the control of these health condition rates are abysmally low. There is also a huge gap between detection and adequate treatment: Less than half of those who have hypertension or diabetes are actually detected. Less than half of those detected receive appropriate treatment and less than half of those receiving treatment have their blood pressure or blood sugar treated to recommended targets. In addition to poor control rates of hypertension and diabetes are a concern as cardiovascular diseases among others could manifest. With the follow-up care model, such complications and increased healthcare costs and premature disability are avoidable. Therefore, there is ample scope to evolve and explore opportunities in managing population healthcare problems, said Tiwari. – PharmaBiz